USE OF BISMUTH DRUGS IN THERAPY OF GASTROENTEROLOGIC PATIENTS AND IN ERADICATION SCHEMES TAKING INTO ACCOUNT MAASTRICHT V RECOMMENDATIONS
https://doi.org/10.21518/2079-701X-2017-15-18-22
Abstract
The article provides Maastricht V recommendations on management of ulcer disease patients. Possibilities of use of bismuth preparations in new recommendations in therapy of pathologies of upper departments of the gastrointestinal tract are considered. Materials of Russian studies on Novobismol drug in therapy of chronic gastritis, ulcer disease are provided by results of which the drug is characterized as effective.
About the Authors
O. N. Minushkin
Центральная государственная медицинская академия Управления делами Президента РФ
Russian Federation
Russian Federation
PhD in medicine, Prof.
T. B. Topchiy
Central State Medical Academy of the Academy of Management of Affairs of the President of the Russian Federation
Russian Federation
Russian Federation
PhD in medicine
A. M. Chebotareva
Central State Medical Academy of the Academy of Management of Affairs of the President of the Russian Federation
Russian Federation
Russian Federation
References
1. Malfertheiner Р, Megraud F, O’Morain СА еt al. Management of Helicobacter pylori infection – the Maastricht V (Florence Consensus Report). Gut, 2016, 10: 1-25.
2. Минушкин О.Н., Топчий Т.Б. Хронический гастрит, новые возможности терапии. Ж. Гастроэнтерологии Санкт-Петербурга, 2014, 1-2: 15-19.
3. Минушкин О.Н., Топчий Т.Б., Иванова О.И. Новобисмол в клинической практике. Методические рекомендации, М., 2015.
4. Старостин Б.Д. Лечение Helicobacter pylori-инфекции – Маастрихтский V (Флорентийский консенсусный отчет) (перевод с комментариями). Журнал Гастроэнтерологии Санкт-Петербурга, 2017, 1: 2-21.
5. Симаненков В.И., Захарова Н.В., Савелова И.В. Сравнительное исследование препаратов Де-Нол и Новобисмол в схемах эрадикации у пациентов с Helicobacter pylori-ассоциированными заболеваниями. Экспериментальная и клиническая гастроэнтерология, 2015, 1(113): 66-71.
Review
For citations:
Minushkin ON, Topchiy TB, Chebotareva AM. USE OF BISMUTH DRUGS IN THERAPY OF GASTROENTEROLOGIC PATIENTS AND IN ERADICATION SCHEMES TAKING INTO ACCOUNT MAASTRICHT V RECOMMENDATIONS. Meditsinskiy sovet = Medical Council. 2017;(15):18-22. (In Russ.) https://doi.org/10.21518/2079-701X-2017-15-18-22
Views:
604
Email this article 